A drug manufacturer announced this week it is recalling lots of blood pressure medication Quinapril after a cancer-causing impurity was discovered, according to an announcement carried by the U.S. Food and Drug Administration (FDA).
Lupin Pharmaceuticals Inc. said that it is voluntarily recalling four lots of Quinapril tablets due to the presence of nitrosamine, which was observed in recent testing that found levels above the acceptable daily intake level set by regulators. The company noted that it stopped marketing Quinapril tablets in September 2022.
According to the announcement, the firm has not received any reports of illnesses connected to the impurity issue. The impurity was found in 20 mg and 40 mg tablets of the drug shipped across the United States. Affected lot numbers are G102929, G100533, G100534, and G203071, and they have expiration dates of April 2023, December 2022, and March 2024….